Doctors FDA Food and Drug Administration Government 
European Pharmaceutical Review
APRIL 13, 2023
As psychedelics diffused into wider society and recreational use increased, some individuals reported…ongoing symptoms after the drugs had left the body” At a time when psychiatry lacked effective medical therapies, the discovery of LSD was of interest.
PM360
AUGUST 9, 2022
Brand Beat: Juul Fights FDA Ban. Shortly after banning Juul from selling its products, the FDA placed a hold on its decision in order to review the company’s case more closely. however, the company is required to prove to the FDA that their e-cigarettes in fact benefit the public. appeals court in Washington, D.C.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 23, 2022
The prevalence of fake drugs is a continually growing problem worldwide. Fake drugs can be categorised as substandard, falsified, counterfeit and diverted drugs, and the World Health Organization (WHO) broadly defines a counterfeit medicine as “one which is deliberately and fraudulently mislabelled with respect to identity and/or source.”
Medico Reach
OCTOBER 17, 2022
Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. Hence, there are obstacles like restrictive, albeit necessary, government regulations. This focus on advanced implants also extends to smart technology.
Medico Reach
OCTOBER 17, 2022
Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. Hence, there are obstacles like restrictive, albeit necessary, government regulations. This focus on advanced implants also extends to smart technology.
pharmaphorum
SEPTEMBER 28, 2022
Understanding these differences across diverse populations can help doctors and HCPs determine what medication and dosage best fit a patient. Food and Drug Administration (FDA). Martin is also the primary author of the pivotal FDA guidance document Collection of Race and Ethnicity Data in Clinical Trials.
Cadensee
JULY 20, 2021
It's become the main thing that the doctors are looking at now. And did you know at the time that you were a trailblazer in this space? It broke the confines of you being a doctor learning healthcare, learning to be a medical profession and that stayed there; it just broke it all. Interview Transcription (mild edits).
Expert insights. Personalized for you.
114 
Let's personalize your content